pI: 9.4025 |
Length (AA): 734 |
MW (Da): 83618 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
12 | 184 | 4nj4 (B) | 82 | 274 | 20.00 | 0 | 0.87 | 0.85459 | 0.38 |
16 | 217 | 3tht (C) | 134 | 336 | 34.00 | 0.00000000016 | 0.99 | 0.91769 | 0.55 |
72 | 140 | 4npl (A) | 95 | 168 | 35.00 | 0.19 | 0.32 | 0.387414 | 1.55 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129632)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G20350 | oxidoreductase |
Caenorhabditis elegans | CELE_B0564.2 | Protein B0564.2 |
Cryptosporidium parvum | cgd3_990 | CG6144-like AlkB |
Dictyostelium discoideum | DDB_G0288517 | hypothetical protein |
Drosophila melanogaster | Dmel_CG6144 | CG6144 gene product from transcript CG6144-RB |
Echinococcus granulosus | EgrG_000841800 | nucleic acid binding |
Echinococcus multilocularis | EmuJ_000841800 | nucleic acid binding |
Homo sapiens | ENSG00000239382 | alkB, alkylation repair homolog 6 (E. coli) |
Leishmania braziliensis | LbrM.35.5200 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_365180.1 | 2OG-Fe(II) oxygenase superfamily, putative |
Leishmania infantum | LinJ.36.5180 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4950 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4950 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_00731 | hypothetical protein |
Mus musculus | ENSMUSG00000042831 | alkB, alkylation repair homolog 6 (E. coli) |
Oryza sativa | 4348649 | Os10g0420000 |
Onchocerca volvulus | OVOC5079 |
|
Schistosoma japonicum | Sjp_0090770 | Alkylated DNA repair protein alkB homolog 6, putative |
Schistosoma japonicum | Sjp_0202860 | ko:K10768 alkylated DNA repair protein alkB homolog 6, putative |
Schistosoma mansoni | Smp_120440.1 | nucleic acid binding |
Schistosoma mansoni | Smp_120440.2 | nucleic acid binding |
Schistosoma mansoni | Smp_192130 | nucleic acid binding |
Schmidtea mediterranea | mk4.009172.01 | Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 |
Trypanosoma brucei gambiense | Tbg972.11.12280 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.10960 | 2OG-Fe(II) oxygenase superfamily, putative |
Trypanosoma congolense | TcIL3000.11.11680 | 2OG-Fe(II) oxygenase superfamily, putative |
Trypanosoma cruzi | TcCLB.503971.10 | 2OG-Fe(II) oxygenase superfamily, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.2740 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.2740 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.2740 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.2740 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 28.0% | 293 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 26.3% | 285 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 8 | 411 aa | 26.3% | 407 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 28.0% | 157 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 23.6% | 296 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 25.3% | 292 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 26.3% | 331 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 28.0% | 293 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 26.8% | 287 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 33.6% | 271 aa | Compounds | References |